Subject: new IOM study on Shipboard Hazard and Defense
***We invite you to share this announcement of a new study at the Institute of Medicine (IOM) with other interested individuals or organizations***
In response to the Caregivers and Veterans Omnibus Health Services Act of 2010 and an ensuing request from the Department of Veterans Affairs, the IOM has assembled a committee of experts to conduct an epidemiological study comparing the health status of the SHAD veterans with a comparison population. This study will build on knowledge gained from a prior study conducted by IOM between 2003 and 2007.
As part of the data collection process, the committee will plan and conduct meetings to receive suggestions and input from SHAD veterans about their experiences so that the study can be informed by the insights of these veterans.
The first meeting of the Committee on Shipboard Hazard and Defense will take place on January 19-20, 2012, in Washington , DC. A second meeting is planned for February 23-24, 2012 in California .
From 1962 to 1973, more than 5,800 military personnel, mostly Navy personnel and Marines, participated in Project SHAD (Shipboard Hazard and Defense) -- a series of tests of U.S. warship vulnerability to biological and chemical warfare agents. Only some of the involved military personnel were aware of these tests at the time. Many of these tests used simulants, which are substances with the physical properties of chemical or biological warfare agents, that were thought at the time to be harmless. The existence of these tests came to light many decades later.
In 2007, the Institute of Medicine ’s Medical Follow-up Agency (MFUA) published a report on the long term health effects of participation in Project SHAD, based on the results of a health survey (the report is available at http://www.nap.edu/catalog.php?record_id=11900). In the new study, an expert committee will work in conjunction with IOM's MFUA and build on knowledge gained from the previous IOM study. The SHAD II study will use the established list of SHAD participants and the comparison population determined from the prior study.
The results of the study will be reported in a brief IOM report by the study committee and an analytic paper for publication.
Input can be provided to the committee through written comments and materials submitted over the course of the study, and through brief presentations at the committee meetings that will be held in January and February 2012.
Written materials can be submitted to the committee through the IOM staff at the postal address shown below. Please note that any comments or materials submitted to the committee in paper or electronic form will normally become part of the study’s public record.
Questions about the study or providing materials for the committee’s consideration should be directed to study director Lois Joellenbeck (ljoellen@nas.edu) or program associate Jon Sanders (jsanders@nas.edu).
Question
Jerrel
--------------------------------------------------------------------------------
From: Joellenbeck, Lois
Sent: Wednesday, November 09, 2011 2:36 PM
Cc: Joellenbeck, Lois
Subject: new IOM study on Shipboard Hazard and Defense
***We invite you to share this announcement of a new study at the Institute of Medicine (IOM) with other interested individuals or organizations***
In response to the Caregivers and Veterans Omnibus Health Services Act of 2010 and an ensuing request from the Department of Veterans Affairs, the IOM has assembled a committee of experts to conduct an epidemiological study comparing the health status of the SHAD veterans with a comparison population. This study will build on knowledge gained from a prior study conducted by IOM between 2003 and 2007.
As part of the data collection process, the committee will plan and conduct meetings to receive suggestions and input from SHAD veterans about their experiences so that the study can be informed by the insights of these veterans.
The first meeting of the Committee on Shipboard Hazard and Defense will take place on January 19-20, 2012, in Washington , DC. A second meeting is planned for February 23-24, 2012 in California .
The charge to the committee and a list of the membership of the committee is available at http://www8.nationalacademies.org/cp/projectview.aspx?key=IOM-BSP-10-08 and at an IOM study site: http://www.iom.edu/Activities/Veterans/SHADII.aspx
Background
From 1962 to 1973, more than 5,800 military personnel, mostly Navy personnel and Marines, participated in Project SHAD (Shipboard Hazard and Defense) -- a series of tests of U.S. warship vulnerability to biological and chemical warfare agents. Only some of the involved military personnel were aware of these tests at the time. Many of these tests used simulants, which are substances with the physical properties of chemical or biological warfare agents, that were thought at the time to be harmless. The existence of these tests came to light many decades later.
In 2007, the Institute of Medicine ’s Medical Follow-up Agency (MFUA) published a report on the long term health effects of participation in Project SHAD, based on the results of a health survey (the report is available at http://www.nap.edu/catalog.php?record_id=11900). In the new study, an expert committee will work in conjunction with IOM's MFUA and build on knowledge gained from the previous IOM study. The SHAD II study will use the established list of SHAD participants and the comparison population determined from the prior study.
The results of the study will be reported in a brief IOM report by the study committee and an analytic paper for publication.
Input can be provided to the committee through written comments and materials submitted over the course of the study, and through brief presentations at the committee meetings that will be held in January and February 2012.
Written materials can be submitted to the committee through the IOM staff at the postal address shown below. Please note that any comments or materials submitted to the committee in paper or electronic form will normally become part of the study’s public record.
Questions about the study or providing materials for the committee’s consideration should be directed to study director Lois Joellenbeck (ljoellen@nas.edu) or program associate Jon Sanders (jsanders@nas.edu).
Lois Joellenbeck, Dr.P.H.
Study Director
Institute of Medicine
The National Academies
500 Fifth St. N.W.
Washington, DC 20001
202-334-1715
ljoellen@nas.edu
Link to comment
Share on other sites
Top Posters For This Question
3
3
2
1
Popular Days
Dec 16
5
Dec 15
1
Dec 18
1
Dec 19
1
Top Posters For This Question
carlie 3 posts
Jerrel 3 posts
Berta 2 posts
Testvet 1 post
Popular Days
Dec 16 2011
5 posts
Dec 15 2011
1 post
Dec 18 2011
1 post
Dec 19 2011
1 post
8 answers to this question
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now